Serogroup Meningococcal Disease
📧 Sign up to get email alerts when something new happens for Serogroup Meningococcal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age [Phase 2]
Phase 2 trial update for a bivalent vaccine (Rlp2086) assessing safety, tolerability, and immunogenicity in laboratory workers aged 18-65, c…